NH DHHS - Investigating Distribution of Recalled Medication Associated with Multi-State Meningitis Outbreak

Concord, NH – The New Hampshire Department of Health and Human Services

(DHHS), Division of Public Health Services (DPHS) is working with the

Centers for Disease Control and Prevention (CDC) on this investigation into

a national outbreak of fungal meningitis. New England Compounding Pharmacy

of Framingham, Massachusetts produced the recalled medication that, here in

New Hampshire, was distributed to Pain Care LLC, the Somersworth and

Merrimack locations only. Pain Care has sent all the unused recalled

product back to the manufacturer. The steroid medication is used for

injections for pain management.

“We are working very closely with Pain Care who are today working to

contact the roughly 186 patients who received this medication,” said NH’s

Public Health Director Dr. Jose Montero. “We are not aware of any cases in

New Hampshire related to this outbreak at this time. We are also

conducting surveillance to identify people who might be affected by this

situation. We realize this is concerning as this can be an extremely

serious and in some cases fatal illness.”

There are many different types of meningitis, a general term for an

infection or inflammatory process involving the lining of the brain and

central nervous system. The cases under investigation have no relation to

the much more common forms of bacterial or viral meningitis. This

particular form of meningitis in this outbreak is not transmissible from

person to person. The cause of the outbreak is believed to be associated

with the recalled medication but it is still under investigation by the

Centers for Disease Control and Prevention and the Federal Drug


To date, there have been 35 cases and 5 deaths in 6 states. However, the

situation continues to evolve and the number of cases will likely change in

the coming days.

For more information visit the CDC website at www.cdc.gov  or call the DPHS

Bureau of Infectious Disease Control at 603-271-4496.